<PAGE>


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM N-Q


QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY


Investment Company Act file number 811-02151

-------------------------------------------------------------------------------


Bancroft Fund Ltd.

-------------------------------------------------------------------------------

(Exact name of registrant as specified in charter)


65 Madison Avenue, Morristown, New Jersey 07960-7308

-------------------------------------------------------------------------------

(Address of principal executive offices) (Zip code)


Thomas H. Dinsmore

Bancroft Fund Ltd.

65 Madison Avenue

Morristown, New Jersey 07960-7308

(Name and address of agent for service)


Copy to:

Steven B. King, Esq.

Ballard Spahr LLP

1735 Market Street, 51st Floor

Philadelphia, PA 19103-7599



Registrant's telephone number, including area code: 973-631-1177


Date of fiscal year end:  October 31, 2014


Date of reporting period:  January 31, 2014


ITEM 1. SCHEDULE OF INVESTMENTS.






Bancroft Fund Ltd. - Schedule of Investments – unaudited

January 31, 2014


   Principal  Value
   Amount  (Note 1)
Convertible Bonds and Notes - 73.9%      
       
Airlines - 1.6%      
Hawaiian Holdings, Inc., 5.00%, Due 3/15/16, (BBB)  $1,375,000   $1,949,062 
           
Biotechnology - 11.3%          
Array BioPharma Inc., 3.00%, Due 6/1/20, (BBB)   250,000    264,062 
BioMarin Pharmaceutical Inc., 1.50%, Due 10/15/20, (NR)   500,000    545,000 
Cubist Pharmaceuticals, Inc., 1.875%, Due 9/1/20, (A) (1)   1,100,000    1,302,812 
Emergent BioSolutions Inc., 2.875%, Due 1/15/21, (A) (1)   800,000    838,000 
Exelixis, Inc., 4.25%, Due 8/15/19, (BBB)   1,000,000    1,383,750 
Gilead Sciences, Inc., 1.00%, Due 5/1/14, (A)   750,000    2,677,031 
Gilead Sciences, Inc., 1.625%, Due 5/1/16, (A)   1,000,000    3,543,755 
Incyte Corp., 1.25%, Due 11/15/20, (A) (1)   1,000,000    1,452,500 
Merrimack Pharmaceuticals, Inc., 4.50%, Due 7/15/20, (BB)   250,000    267,812 
OPKO Health Inc., 3.00%, Due 2/1/33, (BBB) (1)   400,000    501,250 
Regeneron Pharmaceuticals, Inc., 1.875%, Due 10/1/16, (AA)   250,000    859,375 
         13,635,347 
Capital Markets - 2.2%          
BlackRock Kelso Capital Corp., 5.50%, Due 2/15/18, (BBB)   1,500,000    1,559,062 
FXCM Inc., 2.25%, Due 6/15/18, (AA)   1,000,000    1,110,000 
         2,669,062 
Communications Equipment - 2.5%          
Finisar Corp., 5.00%, Due 10/15/29, (NR)   75,000    169,219 
Ixia, 3.00%, Due 12/15/15, (A)   500,000    528,750 
Infinera Corp., 1.75%, Due 6/1/18, (A) (1)   1,000,000    1,025,625 
InterDigital, Inc., 2.50%, Due 3/15/16, (A)   1,250,000    1,276,562 
         3,000,156 
Computers & Peripherals - 0.9%          
SanDisk Corp., 1.50%, Due 8/15/17, (BB)   750,000    1,100,156 
           
Construction & Engineering - 0.4%          
Layne Christensen Co., 4.25%, Due 11/15/18, (A) (1)   500,000    506,250 
           
Consumer Finance - 2.5%          
DFC Global Corp., 3.25%, Due 4/15/17, (B)   1,250,000    973,438 
Encore Capital Group, Inc., 3.00%, Due 7/1/20, (BBB) (1)   1,250,000    1,522,656 
Portfolio Recovery Associates, Inc., 3.00%, Due 8/1/20, (A) (1)   500,000    542,188 
         3,038,282 
Diversified Telecommunications Services - 0.7%          
Alaska Communications Systems Group, Inc., 6.25%, Due 5/1/18, (BB)   1,000,000    852,500 
           
Electrical Equipment - 0.3%          
SolarCity Corp., 2.75%, Due 11/1/18, (BBB)   250,000    351,406 
           
Electronic Equipment Instruments - 0.9%          
InvenSense, Inc., 1.75%, Due 11/1/18, (AA) (1)   1,000,000    1,136,875 






Bancroft Fund Ltd. - Schedule of Investments - continued

January 31, 2014


   Principal  Value
   Amount  (Note 1)
Convertible Bonds and Notes - continued          
           
Energy Equipment & Services - 2.3%          
Bristow Group Inc., 3.00%, Due 6/15/38, (BB)  $1,356,000   $1,617,030 
Hornbeck Offshore Services, Inc., 1.50%, Due 9/1/19, (BB)   1,000,000    1,113,800 
         2,730,830 
Food Products - 0.6%          
Chiquita Brands International, 4.25%, Due 8/15/16, (CCC)   700,000    692,562 
           
Health Care Equipment & Supplies - 0.7%          
Insulet Corp., 3.75%, Due 6/15/16, (A)   500,000    832,500 
           
Health Care Providers & Services - 1.1%          
Molina Healthcare Inc., 1.125%, Due 1/15/20, (A) (1)   1,250,000    1,358,594 
           
Health Care Technology - 0.7%          
Allscripts Healthcare Solutions, Inc., 1.25%, Due 7/1/20, (A) (1)   750,000    882,188 
           
Hotels, Restaurants & Leisure - 1.2%          
MGM Resorts International, 4.25%, Due 4/15/15, (B)   1,000,000    1,405,625 
           
Household Durables - 1.7%          
Jarden Corp., 1.875%, Due 9/15/18, (BB)   1,500,000    2,101,875 
           
Insurance - 0.8%          
AmTrust Financial Services, Inc., 5.50%, Due 12/15/21, (A)   750,000    977,812 
           
Internet & Catalog Retail - 2.4%          
Priceline.com Inc., 1.00%, Due 3/15/18, (BBB)   1,715,000    2,363,484 
Shutterfly, Inc., 0.25%, Due 5/15/18, (A) (1)   500,000    522,500 
         2,885,984 
Internet Software & Services - 3.4%          
Cardtronics, Inc., 1.00%, Due 12/1/20, (A)   750,000    718,129 
Equinix, Inc., 3.00%, Due 10/15/14, (B)   1,000,000    1,657,500 
Move, Inc., 2.75%, Due 9/1/18, (A) (1)   500,000    526,562 
Web.com Group, Inc., 1.00%, Due 8/15/18, (A)   1,000,000    1,180,625 
         4,082,816 
IT Services - 1.4%          
CSG Systems International, Inc., 3.00%, Due 3/1/17, (AA)   1,250,000    1,707,031 
           
Life Science Tools & Services - 1.1%          
Illumina, Inc., 0.25%, Due 3/15/16, (AA) (1)   750,000    1,380,000 
           
Machinery - 0.9%          
Chart Industries, Inc., 2.00%, Due 8/1/18, (B)   750,000    1,065,469 






Bancroft Fund Ltd. - Schedule of Investments – continued

January 31, 2014


   Principal  Value
   Amount  (Note 1)
Convertible Bonds and Notes - continued      
       
Media - 0.8%      
Liberty Media Corp., 1.375%, Due 10/15/23, (AA) (1)  $1,000,000   $931,250 
           
Metals & Mining - 3.2%          
A.M. Castle & Co., 7.00%, Due 12/15/17, (BBB)   400,000    612,600 
Kaiser Aluminum Corp., 4.50%, Due 4/1/15, (BB)   1,000,000    1,486,870 
RTI International Metals, Inc., 3.00%, Due 12/1/15, (A)   600,000    656,250 
RTI International Metals, Inc., 1.625%, Due 10/15/19, (A)   500,000    512,188 
Royal Gold, Inc., 2.875%, Due 6/15/19, (A)   600,000    610,875 
         3,878,783 
Oil, Gas & Consumable Fuels - 2.0%          
Clean Energy Fuels Corp., 5.25%, Due 10/1/18, (BBB) (1)   500,000    493,750 
Goodrich Petroleum Corp., 5.00%, Due 10/1/32, (CCC)   993,000    1,084,232 
Ship Finance International Ltd., 3.25%, Due 2/1/18, (B)   750,000    792,656 
         2,370,638 
Pharmaceuticals - 2.3%          
Mylan Inc., 3.75%, Due 9/15/15, (BBB)   500,000    1,713,125 
Salix Pharmaceuticals, Ltd., 2.75%, Due 5/15/15, (B)   300,000    637,688 
Salix Pharmaceuticals, Ltd., 1.50%, Due 3/15/19, (B)   300,000    482,250 
         2,833,063 
Real Estate Investment Trusts - 3.4%          
American Realty Capital Properties, Inc., 3.00%, Due 8/1/18, (A)   1,000,000    1,027,500 
Colony Financial, Inc., 5.00%, Due 4/15/23, (AA)   1,250,000    1,316,406 
IAS Operating Partnership LP, 5.00%, Due 3/15/18, (NR)          
 (exchangeable for Invesco Mortgage Capital Inc. common stock)   500,000    477,812 
Lexington Realty Trust, 6.00%, Due 1/15/30, (BBB)   500,000    801,562 
RAIT Financial Trust, 4.00%, Due 10/1/33, (BBB)   500,000    493,125 
         4,116,405 
Real Estate Management - 0.8%          
Forest City Enterprises, Inc., 3.625%, Due 8/15/20, (B)   1,000,000    1,010,625 
           
Semiconductors & Semiconductor Equipment - 8.4%          
GT Advanced Technologies Inc., 3.00%, Due 10/1/17, (BBB)   500,000    761,250 
GT Advanced Technologies Inc., 3.00%, Due 12/15/20, (BBB)   500,000    563,125 
JinkoSolar Holding Co., Ltd., 4.00%, Due 2/1/19, (NR) (1)   500,000    452,500 
Micron Technology, Inc., 3.125%, Due 5/1/32, (BB)   250,000    607,969 
Micron Technology, Inc., 3.00%, Due 11/15/43, (BB)   1,250,000    1,325,781 
NVIDIA Corp., 1.00%, Due 12/1/18, (BB) (1)   1,000,000    1,025,625 
Photronics, Inc., 3.25%, Due 4/1/16, (A)   1,000,000    1,080,000 
ReneSola Ltd., 4.125%, Due 3/15/18, (BB)   250,000    196,575 
Rudolph Technologies Inc., 3.75%, Due 7/15/16, (A)   500,000    557,500 
Spansion LLC, 2.00%, Due 9/1/20, (B) (1)   500,000    623,750 
SunEdison, Inc., 2.75%, Due 1/1/21, (BB) (1)   500,000    599,062 
SunPower Corp., 4.50%, Due 3/15/15, (BBB)   1,000,000    1,495,000 
Xilinx, Inc., 2.625%, Due 6/15/17, (A)   500,000    805,625 
         10,093,762 






Bancroft Fund Ltd. - Schedule of Investments - continued

January 31, 2014


   Principal  Value
   Amount  (Note 1)
Convertible Bonds and Notes - continued          
           
Software - 6.9%          
Bottomline Technologies, Inc., 1.50%, Due 12/1/17, (A)  $750,000   $989,531 
Mentor Graphics Corp., 4.00%, Due 4/1/31, (AA)   1,000,000    1,213,125 
NQ Mobile Inc., 4.00%, Due 10/15/18, (BB) (1)   500,000    440,000 
Nuance Communications, Inc., 2.75%, Due 11/1/31, (NR) (1)   2,000,000    1,992,500 
Proofpoint, Inc., 1.25%, Due 12/15/18, (AA) (1)   1,000,000    1,244,375 
Take-Two Interactive Software, Inc., 1.75%, Due 12/1/16, (A)   1,250,000    1,513,281 
TeleCommunication Systems, Inc., 7.75%, Due 6/30/18, (BBB)   1,000,000    975,000 
         8,367,812 
Textiles, Apparel & Luxury Goods - 2.2%          
Iconix Brand Group, Inc., 1.50%, Due 3/15/18, (A)   750,000    979,688 
Iconix Brand Group, Inc., 2.50%, Due 6/1/16, (A)   1,250,000    1,638,281 
         2,617,969 
Trading Companies & Distributors - 0.8%          
Kaman Corp., 3.25%, Due 11/15/17, (A)   750,000    953,438 
           
Wireless Telecommunications - 1.5%          
SBA Communications Corp., 4.00%, Due 10/1/14, (AA)   600,000    1,835,250 
           
Total Convertible Bonds and Notes        89,351,377 
           
Convertible Preferred Stock - 13.2%          
    

 Shares

      
Commercial Banks - 3.2%          
Huntington Bancshares, Inc., 8.50%, (BB)   1,250    1,575,000 
Wells Fargo & Co., 7.50%, (BBB)   2,000    2,315,000 
         3,890,000 
Diversified Financial Services - 1.7%          
Bank of America Corp., 7.25%, (BB)   1,800    2,013,498 
           
Food Products - 1.9%          
Post Holdings, Inc., 3.75%, (B)   8,300    1,020,568 
Post Holdings, Inc., 2.50%, (B) (1)   5,000    532,500 
Bunge Ltd., 4.875%, (BB)   7,500    776,250 
         2,329,318 
Machinery - 0.8%          
Stanley Black & Decker, Inc., 6.25%, (BBB)   10,000    1,015,900 
           
Oil, Gas & Consumable Fuels - 1.8%          
Chesapeake Energy Corp., 5.75%, (B)   1,550    1,772,270 
Halcon Resources Corp., 5.75%, (CCC)   500    360,000 
         2,132,270 






Bancroft Fund Ltd. - Schedule of Investments - continued

January 31, 2014


Convertible Preferred Stock - continued      
      Value
   Shares  (Note 1)
Real Estate Investment Trusts - 2.2%          
Health Care REIT, Inc., 6.50%, (BB)   20,000   $1,085,800 
Weyerhaeuser Co., 6.375%, (BBB)   30,000    1,612,200 
         2,698,000 
Specialty Retail - 0.6%          
Amerivon Holdings LLC, 4.00%, (NR) (1,2,3)   643,516    763,660 
Amerivon Holdings LLC, common equity units, (NR) (1,2,3)   272,728    16,364 
         780,024 
Thrift & Mortgage Finance - 1.0%          
New York Community Capital Trust V, 6.00%, (BB)   24,000    1,166,544 
           
Total Convertible Preferred Stock        16,025,554 
           
Mandatory Convertible Securities - 8.9% (4)          
           
Aerospace & Defense - 2.1%          
United Technologies Corp., 7.50%, Due 8/1/15, (BBB)   40,000    2,577,200 
           
Electric Utilities - 1.8%          
NextEra Energy, Inc., 5.599%, Due 6/1/15, (BBB)   7,500    460,350 
NextEra Energy, Inc., 5.799%, Due 9/1/16, (BBB)   10,000    530,600 
NextEra Energy, Inc., 5.889%, Due 9/1/15, (BBB)   20,000    1,197,400 
         2,188,350 
Insurance - 1.8%          
MetLife, Inc., 5.00%, Due 10/8/14, (BBB)   40,000    1,166,000 
Maiden Holdings, Ltd., 7.25%, Due 9/15/16, (NR)   22,500    1,006,650 
         2,172,650 
Multi-Utilities-1.2%          
Dominion Resources, Inc., 6.125%, Due 4/1/16, (BBB)   12,500    699,125 
Dominion Resources, Inc., 6.00%, Due 7/1/16, (BBB)   12,500    700,375 
         1,399,500 
Real Estate Investment Trusts - 1.0%          
Crown Castle International Corp., 4.50%, Due 11/1/16, (B)   12,500    1,219,750 
           
Road & Rail - 1.0%          
Genesee & Wyoming, Inc., 5.00%, Due 10/1/15, (NR)   10,000    1,226,400 
           
Total Mandatory Convertible Securities (4)        10,783,850 
           
Common Stock - 0.9%          
           
Insurance - 0.9%          
MetLife, Inc.   22,680    1,112,454 
           
Total Common Stock        1,112,454 






Bancroft Fund Ltd. - Schedule of Investments - continued

January 31, 2014


   Value
   (Note 1)
Total Convertible Bonds and Notes - 73.9%  $89,351,377 
Total Convertible Preferred Stock - 13.2%   16,025,554 
Total Mandatory Convertible Securities - 8.9%   10,783,850 
Total Common Stock - 0.9%   1,112,454 
Total Investments - 96.9%   117,273,235 
      
Other Assets, Net of Liabilities - 3.1%   3,719,663 
Total Net Assets - 100.0%  $120,992,898 






Bancroft Fund Ltd. - Schedule of Investments – continued

January 31, 2014


(1) Security not registered under the Securities Act of 1933, as amended (the “Securities Act”) (e.g., the security was purchased in a Rule 144A or a Regulation D transaction). The security may be resold only pursuant to an exemption from registration under the Securities Act, typically to qualified institutional buyers. The Fund generally has no rights to demand registration of such securities. The aggregate market value of these unregistered securities at January 31, 2014 was $22,613,336 which represented 18.6% of the Fund’s net assets.


(2) Investment is valued at fair value as determined in good faith pursuant to procedures adopted by the Board of Trustees. It is possible that the estimated value may differ significantly from the amount that might ultimately be realized in the near term, and the difference could be material. The fair value of these securities amounted to $780,024 at January 31, 2014, which represented 0.6% of the Fund's net assets.


(3) Restricted securities include securities that have not been registered under the Securities Act and securities that are subject to restrictions on resale. The Fund may invest in restricted securities that are consistent with the Fund’s investment objective and investment strategies. In some cases, the issuer of restricted securities has agreed to register such securities for resale at the issuer’s expense, either upon demand by the Fund or in connection with another registered offering of the securities. Investments in restricted securities are valued at fair value as determined in good faith in accordance with procedures adopted by the Board of Trustees. It is possible that the estimated value may differ significantly from the amount that might ultimately be realized in the near term, and the difference could be material. As of January 31, 2014, the Fund was invested in the following restricted securities:


Security Acquisition Date Shares Cost Price per
Share
Value % Net
Assets

Amerivon Holdings LLC

series A 4.00% cv. pfd.

April 1, 2010 643,516 $1,500,000 $1.187 $763,660 0.6%
             

Amerivon Holdings LLC

common equity units

April 1, 2010 272,728 0   0.060    16,364 0.0%

 

 

(4) Mandatory Convertible Securities are required to be converted on the dates listed; they generally may be converted prior to these dates at the option of the holder.


PORTFOLIO RATINGS:


Where a security is rated by Standard & Poor’s, such rating appears in parentheses next to such security (but without any applicable + or - that might apply).


Where a security is rated by Standard & Poor’s and at least one other rating agency and the Fund believes the ratings to be functionally equivalent to one another, the Standard & Poor’s rating appears in parentheses next to such security (but without any applicable + or - that might apply).


Where a security is rated by Standard & Poor’s and at least one other rating agency and the Fund believes the ratings not to be functionally equivalent to one another, the Fund puts in parentheses next to such security the Standard & Poor’s rating which it believes approximates the average of all such ratings (but without any applicable + or - that might apply).


Where a security is not rated by Standard & Poor’s, but is rated by at least one other rating agency, the Fund puts in parentheses next to such security the Standard & Poor’s rating which it believes approximates the average of all such ratings (but without any applicable + or - that might apply). NR is used whenever a rating is unavailable.


SUMMARY OF PORTFOLIO RATINGS *

AAA

0%

AA

11%

A

27%

BBB

26%

BB

17%

B

11%

CCC & below

 2%

Not Rated

6%

 

 

* Excludes common stocks and cash.


See accompanying notes.






Bancroft Fund Ltd. - Selected Notes to Financial Statements - unaudited


Bancroft Fund Ltd. (the “Fund”), is registered under the Investment Company Act of 1940, as amended, (the “Act”) as a diversified, closed-end management investment company.


Note 1 - Security Valuation - Investments in securities traded on a national securities exchange are valued at market using the last reported sales price, supplied by an independent pricing service, as of the close of regular trading. Listed securities, for which no sales were reported, are valued at the mean between closing reported bid and asked prices as of the close of regular trading. Unlisted securities traded in the over-the-counter market are valued using an evaluated quote provided by the independent pricing service, or, if an evaluated quote is unavailable, such securities are valued using prices received from dealers, provided that if the dealer supplies both bid and asked prices, the price to be used is the mean of the bid and asked prices. The independent pricing service derives an evaluated quote by obtaining dealer quotes, analyzing the listed markets, reviewing trade execution data and employing sensitivity analysis. Evaluated quotes may also reflect appropriate factors such as individual characteristics of the issue, communications with broker-dealers, and other market data. Securities for which quotations are not readily available, restricted securities and other assets are valued at fair value as determined in good faith pursuant to procedures approved by the Board of Trustees. Short-term debt securities with original maturities of 60 days or less are valued at amortized cost.

 

The Fund has adopted authoritative fair valuation accounting standards which establish an authoritative definition of fair value and set out a hierarchy for measuring fair value. These standards require additional disclosures about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion in changes in valuation techniques and related inputs during the period. These inputs are summarized in the three broad levels listed below:


Level 1 - Quoted unadjusted prices for identical instruments in active markets.

 

Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-driven valuation in which all significant inputs and significant value drivers are observable in active markets. Level 2 inputs are those in markets for which there are few transactions, the prices are not current, little public information exists or instances where prices vary substantially over time or among brokered market makers, and those received from an independent pricing service.


Level 3 - Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. Unobservable inputs are those inputs that reflect the Fund’s own assumptions that market participants would use to price an asset or liability based on the best available information.


The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of the markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.






Bancroft Fund Ltd. - Selected Notes to Financial Statements - continued


The following is a summary of the inputs used to value the investments of the Fund as of
January 31, 2014:


   Level 1  Level 2  Level 3  Totals
                     
Investments in Securities:                    
Common Stock  $1,112,454   $   $   $1,112,454 
                     
Convertible Bonds and Notes       89,351,377        89,351,377 
 
Convertible Preferred Stock:
                    
    Commercial Banks       3,890,000        3,890,000 
    Diversified Financial Services       2,013,498        2,013,498 
    Food Products       2,329,318        2,329,318 
    Machinery       1,015,900        1,015,900 
    Oil, Gas & Consumable Fuels       2,132,270        2,132,270 
    Real Estate Investment Trusts       2,698,000        2,698,000 
    Specialty Retail           780,024    780,024 
    Thrift & Mortgage Finance       1,166,544        1,166,544 

Total Preferred Stock

       15,245,530    780,024    16,025,554 
Mandatory Convertible Securities       10,783,850        10,783,850 
Total Investments  $1,112,454   $115,380,757   $780,024   $117,273,235 


Refer to the Fund’s Portfolio of Investments for a detailed breakdown of Common Stock, Convertible Bonds and Notes, Convertible Preferred Stock and Mandatory Convertible Securities. Transfers between levels are recognized at January 31, 2014, the end of the reporting period. The Fund recognized no transfers to or from Level 1 and Level 2.


The following is a reconciliation of assets for which Level 3 inputs were used in determining value:


Description  Investments
in Securities
      
Beginning balance as of October 31, 2013  $780,024 
Proceeds from sales    
Gain/loss    
Change in unrealized appreciation (depreciation)    
Net transfers in/out of Level 3    
Balance as of January 31, 2014  $780,024 




The following table presents additional information about valuation methodologies and inputs used for investments that are measured at fair value and categorized within Level 3 as of January 31, 2014:

 

Fair Value
January 31, 2014

Valuation
Methodologies

Unobservable
Input (1)

Impact to
Valuation from
an Increase in
Input (2)

Amerivon Holdings LLC
series A cv. pfd. and
common equity units

$780,024

Market
Comparables/

Sum of the
Parts
Valuation/

Dividend
Analysis

Liquidity
Discount

Increase



continued on following page






Bancroft Fund Ltd. - Selected Notes to Financial Statements – continued


(1) In determining certain of these inputs, management evaluates a variety of factors including economic conditions, industry and market developments, market valuations of comparable companies and company specific developments.


(2) This column represents the directional change in the fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect.


Note 2 - Securities Transactions and Related Investment Income - Securities transactions are accounted for on the trade date (the date the order to buy or sell is executed) with gain or loss on the sale of securities being determined based upon identified cost. Dividend income is recorded on the ex-dividend date and interest income is recorded on the accrual basis, including accretion of discounts and amortization of non-equity premium.


Note 3 - Federal Income Tax Cost - At January 31, 2014, the cost basis of investments for federal income tax purposes, as well as unrealized appreciation (depreciation) of investment securities on a tax basis were as follows:


Unrealized appreciation  $21,235,425 
Unrealized depreciation   (1,944,541)
Net unrealized appreciation   19,290,884 
      
Cost for federal income tax purposes  $97,982,351 



ITEM 2. CONTROLS AND PROCEDURES.


Conclusions of principal officers concerning controls and procedures.


(a) The Fund’s principal executive officer and principal financial officer have concluded that the Fund’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Act (17 CFR 270.30a-3(c)) are effective as of February 28, 2014 based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 17 CFR 240.15d-15(b)).


(b) There have been no changes in the Fund’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d)) that occurred during the Fund’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Fund’s internal control over financial reporting.


ITEM 3. EXHIBITS.


Certifications of the principal executive officer and the principal financial officer of the Fund, as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)), are filed herewith.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Bancroft Fund Ltd.


By: /s/Thomas H. Dinsmore

     Thomas H. Dinsmore

     Chairman of the Board and

     Chief Executive Officer

     (Principal Executive Officer)


Date: March 28, 2014






Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By: /s/Thomas H. Dinsmore

     Thomas H. Dinsmore

     Chairman of the Board and

     Chief Executive Officer

     (Principal Executive Officer)


Date: March 28, 2014


By: /s/Gary I. Levine

     Gary I. Levine

     Chief Financial Officer

     (Principal Financial Officer)


Date: March 28, 2014